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Objective. To test the safety and efficiency of commercially available thrombectomy catheters in clearing simulated internal
carotid artery (ICA) thrombosis.
Design. Comparative in vitro study.
Materials and methods. A model of the ICA was filled with human thrombus, the ‘circle of Willis’ back pressure was set at
either 10 or 30 cm of water. Five thrombectomy devices (Hydrolyser, Clot Buster, Acolysis System, AngioJet and Fogarty
embolectomy catheter) were compared for (i) efficiency at removing thrombus, (ii) pressure changes at the tip of each device,
and (iii) distal embolisation by flow cytometry.
Results. Thrombus clearance was greatest with the AngioJet (median 95%, range 92–97%) and least with the Acolysis
System (median 34%, range 12–50%). The Clot Buster and Hydrolyser were safest as they produced only negative tip
pressures, the AngioJet and Balloon catheter produced positive and negative pressures risking distal embolisation. The
Acolysis system produced no pressure change during use. Distal embolisation (of particles between 5 and 40 mm diameter)
was greatest with the Fogarty balloon catheter at 10 cm water (P , 0.05) and least with the Hydrolyser and Clot Buster.
Conclusion. Balloon embolectomy for ICA thrombosis risks further embolic cerebral damage. The Hydrolyser and the Clot
Buster show the greatest promise for ICA thrombectomy.
Key Words: Carotid thrombosis; Stroke; Thrombectomy; Embolisation.
Introduction
Stroke is the most frequent cause of disability and the
third most common cause of death in the Western
World.1 Using the Oxfordshire Community Stroke
Project classification,2 25% of patients with total
anterior circulation infarction will have suffered recent
internal carotid artery (ICA) thrombosis.3 As part of a
programme researching surgical management of acute
anterior circulation stroke,4 we investigated the use of
mechanical thrombectomy devices in acutely throm-
bosed ICAs.
A number of clinical trials on urgent carotid surgery
for acute stroke were performed in the 1960s and
1970s, with poor results.5 – 7 Many of the studies had
broad entry criteria including patients with dense
strokes and altered consciousness and most did not
have the benefit of computerized tomography to
exclude haemorrhagic stroke. However, the nihilistic
attitude to the treatment of stroke has been challenged
by the advent of thrombolysis.8 Unfortunately, if
thrombolysis is not given soon after the onset of
symptoms the risk of cerebral haemorrhagic out-
weighs the benefit of reperfusion.8 Furthermore, it
seems that large thrombus volumes (as encountered in
ICA thrombosis) are less likely to respond to throm-
bolysis without distal embolisation.9 Mechanical
methods of clearing acutely thrombosed ICAs may
have a role in the treatment of acute stroke if they can
be used without causing distal embolisation.
Little of the current research on thrombectomy
devices, designed for use in peripheral and coronary
arteries, is relevant to the unique anatomy and
physiology of the ICA. Our aim was to investigate
the safety and efficacy of commercially available
thrombectomy devices in an in vitro model of complete
ICA thrombosis, initially with a view to their use
during open carotid thromboendarterectomy.
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Methods
Thrombectomy devices
Four devices were investigated and compared with a
standard ‘Fogarty’ balloon embolectomy catheter. The
devices tested were (i) the Cordis ‘Hydrolyser’, (ii) the
Possis Medical ‘AngioJet’, (iii) the Angiosonics ‘Aco-
lysis System’ and (iv) the Microvena ‘Clot Buster’. The
first two devices consist of biluminal tubes; one lumen
delivering saline at high pressure and the other, wider,
lumen functioning as an exhaust conduit. The high
pressure jet of saline is directed retrograde (i.e.
towards the operator). The jet of saline produces an
area of low pressure (Venturi effect) drawing throm-
bus into the exhaust channel for fragmentation and
removal. The Acolysis system fragments thrombus by
supplying ultrasound energy at the device tip at a
frequency that causes dissolution of fibrin polymers—
with the advantage that the surrounding cells (vessel
wall and blood) are relatively unaffected. The Clot
Buster is based on a propeller housed in a tubular tip
that draws thrombus into the housing and fragments
it. The devices are shown in Fig. 1 and the character-
istics of each device are summarised in Table 1. Advice
and training was provided on the use of each device.
Some of the devices were designed to be used with
guidewires. However, because of the risk of distal
embolisation by manipulating a guidewire into
thrombus within the ICA, all the experiments were
performed without using guidewires.
Model design and outcome measures
The experiment was designed to assess three main
outcome measures:
1. thrombus clearance;
2. pressure changes at the catheter tip on activation;
3. distal embolisation.
ICA thrombosis model
The complex course of the ICA through the base of the
skull was recreated, using measurements taken from
cadaveric specimens, in acrylic resin (Perspex). The
block was constructed so that it could be divided
down the longitudinal axis of the vessel to provide two
half sections of the vessel rather like gutters running
along the cut surface of the block. To allow for the
three-dimensional structure of the ICA, the final
model consisted of four sections (Fig. 2).
Thrombi were produced from fresh human blood
drawn from the same individual for all experiments. It
was allowed to stand for 24 h in 4 mm diameter glass
tubes to produce standardised thrombi. The clot was
then removed from the tube and laid into one side of
the model. The matching side of the model was then
placed over it and bolted into position.
In a retrospective review of angiograms and
attempted embolectomy in patients with stroke caused
by ICA thrombosis, Hugenholtz et al. described a
grading system based on the extent of the thrombo-
sis.10 They found that proximal ICA thrombosis,
(limited to the ICA segment proximal to the sella)
Fig. 1. Thrombectomy catheters: (a) Clot Buster, (b) AngioJet, (c) Acolysis, (d) Hydrolyser, (e) Fogarty.
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was associated with a success rate of 87% compared
with 0% in patients with thrombus throughout the
length of the ICA. We, therefore, decided to simulate
the worst case scenario and produce a model of
‘complete’ ICA thrombosis. The thrombus was, there-
fore, positioned so that it extended throughout the
course of the entire ICA.
The distal (or cerebral) end of the model artery
ended at a ‘T’ junction. This allowed saline to flow
over the distal end of the thrombus—as blood
circulating in the ‘circle of Willis’ does in a completely
thrombosed ICA.11 The ‘circle of Willis‘ pressures were
set at either 30 and 10 cm of water to conservatively
simulate the back pressures dependent on the quality
of the collateral blood supply.12 Distal embolisation
was measured with two pressure ranges for the distal
end of the ‘internal carotid’ representing circle of
Willis pressures of 10 and 30 cm water.
Thrombus clearance was expressed as percent wet
weight reduction obtained by subtracting the weight
of the model prior to and following thrombectomy
with each device.
Distal embolisation was measured by collecting the
perfusate passing along the ‘circle of Willis’ over the
distal thrombus. This was immediately passed
through a flow cytometer (Coulter XL) gated to
count particles in the following size ranges; (i) less
than 5 mm, (ii) between 5 and 40 mm and (iii) above
40 mm diameter. These size ranges were chosen as
particles smaller than 5 mm would pass through
cerebral capillaries with no detrimental effect on the
brain. Those between 5 and 40 mm would be trapped
in capillaries and arterioles and those above 40 would
embolise to larger vessels causing ischaemic damage.
Five 30 ml aliquots were measured from each run with
each device. The mean number of particles produced
per run was recorded and expressed as emboli per ml.
Pilot studies demonstrated that emboli were released
from the thrombus before thrombectomy was
attempted. Net embolus production per run was,
therefore, calculated as embolus counts during throm-
bectomy minus the baseline emboli counts.
We tested the pressures generated at the tip of the
thrombectomy devices as a positive pressure could
theoretically lead to distal embolisation. To measure
the pressure change, a section of 4 mm diameter
Portex tubing was connected at one end to a pressure
transducer (Avon Medicals) and recorder (Lectromed
Multitrace 2). The thrombectomy devices were intro-
duced at the other end of the tubing using an 8 French
catheter introducer (Cordis UK). The system was filled
with isotonic saline and calibrated. Pressure changes
on device activation were then recorded in centimeters
of water against time in seconds. Each device was
tested eight times. Experimental conditions were
identical for all devices. The pressure traces for each
device, except the Fogarty balloon catheter, were
invariably identical from study to study.
All data were found to follow non-normal distri-
butions and were analysed using non-parametric tests.
The Kruskal–Wallis test was used to identify differ-
ences between the catheters. The Mann–Whitney
Table 1. Summary of thrombectomy devices
Clot Buster Angiojet Hydrolyser Acolysis Balloon
Company Microvena, USA Possis Medical, USA Cordis, Netherlands Angiosonics, USA Intimax, USA
Principle Impeller Venturi Venturi Ultrasound Fogarty
Length (cm) 50–120 140 65–135 120 100
Tip diam. (Ch) 8 5 7 7 5
Opening to clot Front 360 degrees Side 3608 N/A
Guidewire No Yes Yes Yes No
Power source Compressed air Purpose built unit Power injector Purpose built unit N/A
Fig. 2. Internal carotid artery thrombosis model.
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U-test, with Bonferroni’s correction was employed to
locate specific differences. Significance was set at the
conventional 5% level.
Results
One of the reasons for the widespread use of the
Fogarty balloon catheter is its inherent simplicity.
None of the other devices were as simple to use. The
AngioJet and Acolysis System both required purpose
built power sources and were cumbersome. The
Hydrolyser requiring a pressure injector (not usually
available in operating theatres) and the Clot Buster
with a simple foot pedal to control the flow of
compressed air from a free standing cylinder were
both more convenient to use than either the AngioJet
or the Acolysis System.
Thrombus clearance
Thrombus clearance with the AngioJet was 95% (93–
96) and this was significantly more efficient than all of
the other devices ðP , 0:05Þ (Table 2). Clearance with
the Acolysis System was only 34% (44–26), signifi-
cantly worse when compared with all other devices.
Of the remaining devices, the Fogarty balloon, with
a clearance of 90% (88–91) was significantly ðP , 0:05Þ
more efficient than the Hydrolyser at 80% (70–89). The
Clot Buster achieved 88% (74–93) clearance. Because
of the poor performance of the Acolysis System, it was
not evaluated further in subsequent studies.
Pressure changes
Pressure changes with the Fogarty balloon catheter
were highly variable (Table 3). An initial positive
pressure (over 100 cm water) was recorded when the
balloon was inflated, followed by a fall in pressure on
retraction of the catheter. This pressure fall was
entirely dependent on the force of traction applied
by the operator.
The Clot Buster and the Hydrolyser both produced
a sustained fall in pressure of 250 cm water, the
former producing the most rapid fall in pressure.
Positive pressures were not detected with either of
these devices. The AngioJet produced a pulsatile
pressure trace, with a negative pressure ranging
between 230 and 250 cm water but with brief
elevations in pressure to over þ 100 cm water. Each
pressure cycle lasted approximately 1.5 s with positive
pressure over approximately 0.15 s.
Distal embolisation
Circle of Willis pressure 10 cm H2O
Emboli between 5 and 40 mm. A median (range) of 1200
(87 to 1.0 £ 104) emboli per ml, were counted in the
‘circle of Willis’ saline with the Fogarty balloon;
significantly higher than any of the other devices
(Tables 4a and 4b). There was no significant difference
between the other three devices at this circle of Willis
pressure with net embolus production of 227 (2240
to 53) for the Clot Buster, 27 (2147 to 0) for the
Hydrolyser and 7 (2193 to 93) for the AngioJet. There
was a fall in embolus production from control values
during use of the Hydrolyser and the Clot Buster.
Emboli above 40 mm. The median number of emboli per
ml for the Fogarty balloon, Hydrolyser and Clot Buster
was 0 with ranges of 27 to 7, 0 to 33, 0 to 7,
respectively. The AngioJet consistently avoided distal
embolisation. During the use of the Fogarty balloon
one large embolus, approximately 0.5 cm diameter,
was extruded from the test rig into the circle of Willis.
Circle of Willis pressure 30 cm H2O
Emboli between 5 and 40 mm. At this pressure, the
median number of emboli counted distally with the
Fogarty balloon was 33 (2306 to 4400). The other
devices all reduced emboli counts; 250 (2120 to 7) for
the Hydrolyser, 27 (247 to 7) for the Clot Buster and
23 (233 to 13) for the AngioJet as saline in the distal
‘circle of Willis’ tubing was drawn down the test
Table 2. Percent thrombus clearance for the five devices tested
Angiojet Acolysis Clot Buster Hydrolyser Balloon
No. expts 9 9 9 9 6
Median (%) 95 34 88 80 90
Interquartile range 93–96 26–44 74–93 70–89 88–91
Table 3. Summary of pressure changes during device activation
Device Recorded pressure change Pressure change profile
Angiojet 250 to .100 cm water Pulsatile
Acolysis 0 N/A
Clot Buster 250 cm water Rapid and sustained
Hydrolyser 250 cm water Rapid and sustained
Balloon N/R Operator dependant
N/R, not recorded. See text. N/A, not applicable.
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‘internal carotid’ into the thrombectomy device. There
were however, no statistically significant differences
between of the devices for emboli of this size at this
back pressure.
Emboli above 40 mm. Emboli in this size range were few
at this circle of Willis pressure. No emboli were
recorded for the Hydrolyser, Clot Buster or AngioJet.
The Fogarty balloon catheter again produced one
macroscopic embolus too large to be detected by flow
cytometry.
In summary, at low ‘circle of Willis’ pressures, the
Fogarty balloon produced macroscopic emboli and
significantly more emboli between 5 and 40 mm than
the other devices. At higher circle of Willis pressures,
the Fogarty balloon again caused a large embolus to
pass distally. Only the Clot Buster and Hydrolyser
produced net negative emboli counts at both back
pressures.
Discussion
Acutely thrombosed ICAs may be cleared using a
thrombectomy device; at least in this experimental
model. The devices performed very differently in
terms of efficacy and safety with the outcomes
employed in this model. The Fogarty balloon pro-
duced high pressures and dramatic distal embolisa-
tion confirming the clinical experience that this
catheter should not be used in the ICA. We found a
wide range of safety and efficiency between the
devices. Although the AngioJet was the most efficient
at removing thrombus, distal embolisation was a
problem with surges of high tip pressure suggesting
that the device may not be a safe for use in the ICA.
The Acolysis System, designed for small thrombus
volumes in the coronary circulation, could not
adequately clear the thrombus volume encountered
in this model. The Hydrolyser and Clot Buster have
the lowest tendency to cause distal embolisation,
presumably as both devices produced consistently
negative tip pressures during use.
There have been few studies on the use of
thrombectomy devices in the ICA. Edwards et al.
described the use of gentle suction to remove
thrombus12 but perversely, it was the advent of the
Fogarty balloon embolectomy catheter that made ICA
thrombectomy more widespread.13 There are several
reports on carotid thromboendarterectomy occasion-
ally including the use of Fogarty balloon cath-
eters.14 – 20 Distal embolisation was not measured and
it was impossible to distinguish clinically between
neurological deficits due to surgery and the usually
severe original stroke. Reporting bias may even lead to
the selective publication of more successful cases. We
were alarmed by the frequency of large emboli in our
experiments with the Fogarty balloon catheter; this
catheter should not be used for this indication.
The AngioJet has been used in a patient with carotid
thrombosis following carotid endarterectomy.21 The
thrombus was rapidly removed by the AngioJet device
but the ICA then rethrombosed. Further treatment
with the AngioJet and intraluminal stenting achieved
patency.
Many of the problems posed by the use of
thrombectomy devices in the carotid arteries have
not been addressed in studies on peripheral and
coronary thrombosis. Thrombus clearance was
measured in straight vessels (in vitro and in vivo),
often using guidewires. Distal embolisation was
measured either by weighing filters or by histological
examination of distant organs.22 – 24 Emboli detection
based on weighing of filters would be unlikely to be
sufficiently sensitive to detect the small emboli capable
Table 4a. Summary of embolus production at 10 cm water circle of Willis pressure
Emboli size 5–40 mm median (range) Emboli size .40 mm median (range)
Fogarty balloon 1200 (87 to 1.0 £ 104) 0 (27 to 7)*
Hydrolyser 27 (2147 to 0) 0 (0 to 33)
Clot Buster 227 (2240 to 53) 0 (0 to 7)
AngioJet 7 (2193 to 93) 0 (0)
*One large embolus discharged during balloon inflation, too large to be detected by flow cytometry.
Table 4b. Summary of embolus production at 30 cm water circle of Willis pressure
Emboli size 5–40 mm median (range) Emboli size .40 mm median (range)
Fogarty Balloon 33 (2306 to 4400) 0 (267–0)*
Hydrolyser 250 (2120 to 7) 0 (0)
Clot Buster 27 (247 to 7) 0 (0)
AngioJet 23 (233 to 13) 0 (0)
*One large embolus discharged during balloon inflation, too large to be detected by flow cytometry.
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of causing cerebral damage. Flow cytometry has not
been used for this purpose before but proved reliable.
The initial aim of this study was to assess the safety
and efficacy of the devices in open carotid thromboen-
darterectomy. Some of the available devices have been
designed to be introduced over a guidewire; essential
for most endovascular applications. However, the
passage of a guidewire into a thrombosed ICA risks
dislodging emboli distally and we therefore did not
test the devices with guidewires. It is possible,
however, that the use of a distal (i.e. ‘upstream’)
occlusion catheter may eventually provide a safe and
efficient endovascular approach.
The two most promising devices (Hydrolyser and
Clot Buster) are based on different principles, but both
produce consistently negative tip pressures on acti-
vation. Notably, these two devices are relatively easy
to set up and use in an operating theatre. Studies are
now required to assess whether either the Hydrolyser
or the Clot Buster can be used safely during surgery
for acute ICA thrombosis.
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